Brief: Biofrontera Q2 Revenue USD 9 Million
13/08/2025 22:20
Aug 13 (Reuters) - Biofrontera Q2 adjusted EBITDA USD -5.1 million. Q2 net income USD -5.3 million Q2 operating expenses USD 14.1 million
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales